Table 2 Symptom burden (attack frequency, duration and intensity) and lost productivity (work days [HALT 1+2] and household days [HALT 3+4]) in the two samples
Sample | Frequency (days/month) | Duration (hours) | Intensity | HALT 1 +2 (days/3 months) | HALT 3 +4 (days/3 months) | ||
|---|---|---|---|---|---|---|---|
mean ±SEM (median) | Not bad n (%) | Quite bad n (%) | Very bad n (%) | Mean ±SEM (median) | |||
Population-based | |||||||
male | 2.7 ±0.1 (2.0) | 24.9 ±1.2 (6.0) | 104 (5.6) | 1012 (54.7) | 734 (39.7) | 3.3 ±0.2 (1.0) | 3.0 ±0.2 (0.0) |
female | 3.2 ±0.1 (2.0) | 26.7 ±0.9 (12.0) | 162 (5.1) | 1682 (52.8) | 1342 (42.1) | 2.2 ±0.1 (0.0) | 3.9 ±0.2 (2.0) |
Eurolight | |||||||
male | 2.5 ±0.1 (1.7) | 20.9 ±1.1 (8.0) | 164 (19.0) | 522 (60.4) | 178 (20.6) | 2.5 ±0.3 (0.0) | 2.8 ±0.3 (0.0) |
female | 3.3 ±0.1 (2.5) | 37.3 ±1.1 (24.0) | 179 (9.7) | 1138 (61.4) | 536 (28.9) | 2.7 ±0.1 (0.0) | 4.3 ±0.2 (2.0) |